Programmed death-ligand 1: Difference between revisions
Jump to navigation
Jump to search
| Line 31: | Line 31: | ||
*Durvalumab. | *Durvalumab. | ||
*Pembrolizumab | *Pembrolizumab | ||
*Avelumab | |||
===Anti-PD-L1 drugs - use=== | ===Anti-PD-L1 drugs - use=== | ||
| Line 31: | Line 31: | ||
*Durvalumab. | *Durvalumab. | ||
*Pembrolizumab | *Pembrolizumab | ||
*Avelumab | |||
===Anti-PD-L1 drugs - use=== | ===Anti-PD-L1 drugs - use=== | ||